Intestinal microbiota and probiotics in celiac disease

Clinical Microbiology Reviews

Volumn 27, Issue 3, 2014, Pages 482-489

  de Sousa Moraes, Luís Fernando ^a   Grzeskowiak, Lukasz Marcin ^a   de Sales Teixeira, Tatiana Fiche ^a   do Carmo Gouveia Peluzio, Maria ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; AUTOIMMUNITY; CELIAC DISEASE; ENTEROPATHY; HUMAN; IMMUNE FUNCTION TEST; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; PATHOPHYSIOLOGY; ANIMAL; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MICROFLORA;

ANIMALS; CELIAC DISEASE; HUMANS; INTESTINES; MICROBIOTA; PROBIOTICS;

EID: 84903633185     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00106-13     Document Type: Article

References (50)

1. Pozo-Rubio T, Olivares M, Nova E, De Palma G, Mujico JR, Ferrer MD, Marcos A, Sanz Y. 2012. Immune development and intestinal microbiota in celiac disease. Clin. Dev. Immunol. 2012:654143. http://dx.doi.org/10.1155/2012/654143.
2. Schuppan D, Junker Y, Barisani D. 2009. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 137:1912-1933. http://dx.doi.org/10.1053/j.gastro.2009.09.008.
3. Fernández A, González L, De La Fuente J. 2010. Coeliac disease: clinical features in adult populations. Rev. Esp. Enferm. Dig. 102:466-471. http: //www.grupoaran.com/mrmUpdate/lecturaPDFfromXML.asp?IdArt_4 619000&TO_RVN&Eng_1.
4. Roma E, Roubani A, Kolia E, Panayiotou J, Zellos A, Syriopoulou VP. 2010. Dietary compliance and life style of children with celiac disease. J. Hum. Nutr. Diet. 23:176-182. http://dx.doi.org/10.1111/j.1365-277X.2009.01036.x.
5. Wieser H. 2007. Chemistry of gluten proteins. Food Microbiol. 24:115-119. http://dx.doi.org/10.1016/j.fm.2006.07.004.
6. Spurkland A, Sollid LM, Ronningen KS, Bosnes V, Ek J, Vartdal F, Thorsby E. 1990. Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles. Hum. Immunol. 29:157-165. http://dx.doi.org/10.1016/0198-8859(90)90111-2.
7. Fernández-Cavada-Pollo MJ, Alcalá-Peña MI, Vargas-Pérez ML, Vergara-Prieto E, Vallcorba-Gómez-Del Valle I, Melero-Ruiz J, Márquez-Armenteros AM, Romero-Albillos JA, Narváez-Rodríguez I, Fernández-de-Mera JJ, González-Roiz C. 2013. Celiac disease and HLA-DQ genotype: diagnosis of different genetic risk profiles related to the age in Badajoz, southwestern Spain. Rev. Esp. Enferm. Dig. 105:469-476. http: //dx.doi.org/10.4321/S1130-01082013000800005.
8. Kupfer SS, Jabri B. 2012. Pathophysiology of celiac disease. Gastrointest. Endosc. Clin. N. Am. 22:639-660. http://dx.doi.org/10.1016/j.giec.2012.07.003.
9. Lionetti E, Catassi C. 2011. New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int. Rev. Immunol. 30:219-231. http://dx.doi.org/10.3109/08830185.2011.602443.
10. Wapenaar MC, Monsuur AJ, Van Bodegraven AA, Weersma RK, Bevova MR, Linskens RK, Howdle P, Holmes G, Mulder CJ, Dijkstra G, Van Heel DA, Wijmenga C. 2008. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 57:463-467. http://dx.doi.org/10.1136/gut.2007.133132.
11. Kalliomäki M, Satokari R, Lähteenoja H, Vähämiko S, Grönlund J, Routi T, Salminen S. 2012. Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. J. Pediatr. Gastroenterol. Nutr. 54:727-732. http://dx.doi.org/10.1097/MPG.0b013e318241cfa8.
12. Nistal E, Caminero A, Herrán AR, Arias L, Vivas S, Ruiz de Morales JM, Calleja S, Sáenz de Miera LE, Arroyo P, Casqueiro J. 2012. Differences of small intestinal bacteria populations in adults and children with/ without celiac disease: effect of age, gluten diet, and disease. Inflamm. Bowel Dis. 18:649-656. http://dx.doi.org/10.1002/ibd.21830.
13. Collado M, Calabuig M, Sanz Y. 2007. Differences between the fecal microbiota of coeliac infants and healthy controls. Curr. Issues Intest. Microbiol. 8:9-14.
14. Van Elburg RM, Uil JJ, Mulder CJ, Heymans HSA. 1993. Intestinal permeability in patients with coeliac disease and relatives of patients with celiac disease. Gut 34:354-357. http://dx.doi.org/10.1136/gut.34.3.354.
15. Fasano A. 2011. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol. Rev. 91:151-175. http://dx.doi.org/10.1152/physrev.00003.2008.
16. Drago S, El Asmar R, Di Pierro M, Grazia Clemente M, Tripathi A, Sapone A, Thakar M, Iacono G, Carroccio A, D'Agate C, Not T, Zampini L, Catassi C, Fasano A. 2006. Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand. J. Gastroenterol. 41:408-419. http://dx.doi.org/10.1080 /00365520500235334.
17. Frazier TH, DiBaise JK, McClain CJ. 2011. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. J. Parenter. Enteral Nutr. 35:14S-20S. http://dx.doi.org/10.1177/0148607111413772.
18. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM. 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58:1091-1093. http://dx.doi.org/10.1136/gut.2008.165886.
19. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. 2011. Human nutrition, the gut microbiome and the immune system. Nature 474:327-336. http://dx.doi.org/10.1038/nature10213.
20. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. 2007. The human microbiome project. Nature 449:804-810. http://dx.doi.org/10.1038/nature06244.
21. Vivas S, Ruiz de Morales JM, Fernandez M, Hernando M, Herrero B, Casqueiro J, Gutierrez S. 2008. Age-related clinical, serological, and histopathological features of celiac disease. Am. J. Gastroenterol. 103:2360-2365. http://dx.doi.org/10.1111/j.1572-0241.2008.01977.x.
22. Nistal E, Caminero A, Vivas S, Ruiz De Morales JM, Sáenz De Miera LE, Rodríguez-Aparicio LB, Casqueiro J. 2012. Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients. Biochimie 94:1724-1729. http://dx.doi.org/10.1016/j.biochi.2012.03.025.
23. Cheng J, Kalliomäki M, Heilig HGHJ, Palva A, Lähteenoja H, de Vos WM, Salojärvi J, Satokari R. 2013. Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease. BMC Gastroenterol. 13:113. http://dx.doi.org/10.1186/1471-230X-13-113.
24. Wacklin P, Kaukinen K, Tuovinen E, Collin P, Lindfors K, Partanen J, Mäki M, Mättö J. 2013. The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm. Bowel Dis. 19:934-941. http://dx.doi.org/10.1097/MIB.0b013e31828029a9.
25. Sanz Y, Sánchez E, Marzotto M, Calabuig M, Torriani S, Dellaglio F. 2007. Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis. FEMS Immunol. Med. Microbiol. 51:562-568. http://dx.doi.org/10.1111 /j.1574-695X.2007.00337.x.
26. Nadal I, Donant E, Ribes-Koninckx C, Calabuig M, Sanz Y. 2007. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J. Med. Microbiol. 56:1669-1674. http://dx.doi.org/10.1099/jmm.0.47410-0.
27. Collado M, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. 2008. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMCMicrobiol. 8:232. http://dx.doi.org/10.1186/1471-2180-8-232.
28. Collado M, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. 2009. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J. Clin. Pathol. 62:264-269. http://dx.doi.org/10.1136/jcp.2008.061366.
29. Di Cagno R, Rizziello CG, Gagliardi F, Ricciuti P, Ndagijimana M, Francavilla R, Guerzoni ME, Crecchio C, Gobbetti M, De Angelis M. 2009. Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease. Appl. Environ. Microbiol. 75:3963-3971. http://dx.doi.org/10.1128/AEM.02793-08.
30. De Palma G, Cinova J, Stepankova R, Tuckova L, Sanz Y. 2010. Pivotal advance: bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease. J. Leukoc. Biol. 87:765-778. http://dx.doi.org/10.1189/jlb.0709471.
31. Di Cagno R, De Angelis M, De Pasquale I, Ndagijimana M, Vernocchi P, Ricciuti P, Gagliardi F, Laghi L, Crecchio C, Guerzoni ME, Gobbetti M, Francavilla R. 2011. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 11:219. http://dx.doi.org/10.1186/1471-2180-11-219.
32. Wang M, Ahrne S, Jeppsson B, Molin G. 2005. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol. Ecol. 54:219-231. http://dx.doi.org/10.1016/j.femsec.2005.03.012.
33. Ouwehand AC, Salminen S, Arvola T, Ruuska T, Isolauri E. 2004. Microbiota composition of the intestinal mucosa: association with fecal microbiota? Microbiol. Immunol. 48:497-500. http://dx.doi.org/10.1111 /j.1348-0421.2004.tb03544.x.
34. Setoyama H, Imaoka A, Ishikawa H, Umesaki Y. 2003. Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients. Microbes Infect. 5:115-122. http://dx.doi.org/10.1016/S1286-4579(02)00080-1.
35. Grzeskowiak LM, Collado MC, Mangani C, Maleta K, Laitinen K, Ashorn P, Salminen S. 2012. Distinct gut microbiota in southeastern African and northern European infants. J. Pediatr. Gastroenterol. Nutr. 54:812-816. http://dx.doi.org/10.1097/MPG.0b013e318249039c.
36. Grzeskowiak LM, Grönlund MM, Beckmann C, Salminen S, von Berg A, Isolauri E. 2012. The impact of perinatal probiotic intervention on gut microbiota: double-blind placebo-controlled trials in Finland and Germany. Anaerobe 18:7-13. http://dx.doi.org/10.1016/j.anaerobe.2011.09.006.
37. Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R, Aguilera M, Khanna S, Gil A, Edwards CA, Doré J. 2010. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J. Pediatr. Gastroenterol. Nutr. 51: 77-84. http://dx.doi.org/10.1097/MPG.0b013e3181d1b11e.
38. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U. S. A. 107:14691-14696. http://dx.doi.org/10.1073/pnas.1005963107.
39. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft HJ, Doré J, Blaut M. 2006. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a crosssectional study. Appl. Environ. Microbiol. 72:1027-1033. http://dx.doi.org/10.1128/AEM.72.2.1027-1033.2006.
40. Tack GJ, Verbeek WHM, Schreurs MWJ, Mulder CJJ. 2010. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat. Rev. Gastroenterol. Hepatol. 7:204-213. http://dx.doi.org/10.1038/nrgastro.2010.23.
41. Fasano A, Catassi C. 2001. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120:636-651. http://dx.doi.org/10.1053/gast.2001.22123.
42. Högberg L, Grodzinsky E, Stenhammar L. 2003. Better dietary compliance in patients with coeliac diseasediagnosedin early childhood. Scand. J. Gastroenterol. 38:751-754. http://dx.doi.org/10.1080/00365520310003318.
43. Bakshi A, Stephen S, Borum ML, Doman DB. 2012. Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet. Gastroenterol. Hepatol. 8:582-588. http://www.ncbi.nlm.nih.gov/pmc /articles/PMC3594957/.
44. Food and Agriculture Organization of the United Nations, World Health Organization. 2002. Guidelines for the evaluation of probiotics in food. World Health Organization, Geneva, Switzerland. ftp://ftp.fao.org /es/esn/food/wgreport2.pdf. Accessed 27 April 2014.
45. Vanderpool C, Yan F, Polk DB. 2008. Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm. Bowel Dis. 14:1585-1596. http://dx.doi.org/10.1002/ibd.20525.
46. De Angelis M, Rizzelo CG, Fasano A, Clemente MG, De Simone C, Silano M, De Vincenzi M, Losito I, Gobbetti M. 2006. VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue. Biochim. Biophys. Acta 1762:80-93. http://dx.doi.org/10.1016/j.bbadis.2005.09.008.
47. Lindfors K, Blomqvist T, Juuti-Uusitalo K, Stenman S, Venäläinen J, Mäki M, Kaukinen K. 2008. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin. Exp. Immunol. 152:552-558. http://dx.doi.org/10.1111/j.1365-2249.2008.03635.x.
48. Laparra JM, Olivares M, Gallina O, Sanz Y. 2012. Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model. PLoS One 7:e30744. http://dx.doi.org/10.1371 /journal.pone.0030744.
49. D'Arienzo R, Stefanile R, Maurano F, Mazzarella G, Ricca E, Troncone R, Auricchio S, Rossi M. 2011. Immunomodulatory effects of Lactobacillus casei administration in a mouse model of gliadin-sensitive enteropathy. Scand. J. Immunol. 74:335-341. http://dx.doi.org/10.1111/j.1365-3083.2011.02582.x.
50. Smecuol E, Hwang HJ, Sugai E, Corso L, Cherñavsky AC, Bellavite FP, González A, Vodánovich F, Moreno ML, Vázquez H, Lozano G, Niveloni S, Mazure R, Meddings J, Mauriño E, Bai JC. 2013. Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis Natren Life Start strain super strain in active celiac disease. J. Clin. Gastroenterol. 47:139-147. http://dx.doi.org/10.1097/MCG.0b013e31827759ac.